https://azd9668inhibitor.com/b....reakthrough-of-the-b
Patients undergoing hepatectomy, distal pancreatectomy, or pancreaticoduodenectomy through the ERAS® program were prospectively enrolled over 10 months. The program supplied education and surveys before surgery through 30 days postdischarge. Thresholds were set for preliminary use regarding the application (75%), PRO reaction price (50%), and patient satisfaction (75%). Constant postdischarge health inspections integrated personalized responses to guide out-of-hospital attention .
Like
Comment
Share
